FIELD: biotechnology.
SUBSTANCE: invention refers to biotechnology and molecular biology. Disclosed is a method for quantitative assessment of viable bacteria in a drug substance for therapy for recovering microbiota (MRT), based on quantitative polymerase chain reaction (qPCR).
EFFECT: invention can be used for quantitative assessment of viable bacteria in medicine.
15 cl, 4 dwg, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS AND METHODS | 2014 |
|
RU2664479C2 |
| METHOD OF ISOLATING AND PRESERVING TOTAL INTESTINAL MICROBIOTA FOR TRANSPLANTATION | 2019 |
|
RU2727444C1 |
| METHOD, COMPOSITION AND KIT FOR STABILIZING DEOXYRIBONUCLEIC ACIDS IN BIOLOGICAL SAMPLES | 2015 |
|
RU2717644C2 |
| METHOD OF IDENTIFYING PATIENT SENSITIVE TO MEDICINAL PRODUCT BASED ON MANNURONIC ACID OLIGOSACCHARIDES AMONG PATIENTS WITH ALZHEIMER'S DISEASE | 2020 |
|
RU2806017C2 |
| COMBINATION CONTAINING FULVIC ACID AND ANTIBIOTICS | 2009 |
|
RU2505295C2 |
| BACTERIAL STRAINS ISOLATED FROM PIGS | 2012 |
|
RU2677890C2 |
| METHOD OF TREATING ALZHEIMER'S DISEASE THROUGH REGULATION OF INTESTINAL MICROORGANISMS | 2020 |
|
RU2810079C2 |
| METHOD FOR TREATMENT OF ALZHEIMER'S DISEASE BY T-CELL INHIBITION OF AMINO ACID UPTAKE | 2020 |
|
RU2791665C1 |
| ANTIBACTERIAL COMPOSITION BASED ON ENDOLYSINS AND DRUGS IN FORM OF GEL OR SPRAY, USING IT | 2021 |
|
RU2790481C1 |
| METHOD OF PREVENTION AND/OR TREATMENT OF INSULIN RESISTANCE | 2012 |
|
RU2613322C2 |
